Current approaches to the diagnosis and treatment of cholangiocarcinoma
暂无分享,去创建一个
[1] M. Nagino,et al. Management of Hilar Cholangiocarcinoma: Comparison of an American and a Japanese Experience , 2000, Annals of surgery.
[2] W. Jarnagin,et al. Surgical management of cholangiocarcinoma. , 2004, Seminars in liver disease.
[3] J. Vauthey,et al. Recent Advances in the Management of Cholangiocarcinomas , 1994, Seminars in liver disease.
[4] M. Pruckmayer,et al. The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. , 1998, European journal of cancer.
[5] P. Schein,et al. 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] R. Schoefl,et al. Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenoses. , 1997, Scandinavian journal of gastroenterology.
[7] K. Takeda,et al. Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers. , 2000, Gastrointestinal endoscopy.
[8] H. Thomas,et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document , 2002, Gut.
[9] B. Malassagne,et al. Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. , 2000, Archives of surgery.
[10] M. Nagino,et al. Lymph Node Metastasis from Hilar Cholangiocarcinoma: Audit of 110 Patients Who Underwent Regional and Paraaortic Node Dissection , 2001, Annals of surgery.
[11] Michael Gregor,et al. Serum and bile markers for cholangiocarcinoma. , 2004, Seminars in liver disease.
[12] J. Lee,et al. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[13] K. Lillemoe,et al. Perihilar Cholangiocarcinoma Postoperative Radiotherapy Does Not Improve Survival , 1995, Annals of surgery.
[14] G. Fiorentini,et al. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5‐fluorouracil in patients with unresectable biliary tract tumors , 2005, Cancer.
[15] R. Jenkins,et al. Aggressive surgical resection for cholangiocarcinoma. , 1995, Archives of surgery.
[16] K. Ido,et al. Characterization of biliary strictures using intraductal ultrasonography: comparison with percutaneous cholangioscopic biopsy. , 1998, Gastrointestinal endoscopy.
[17] W. Silverman,et al. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. , 2002, Gastrointestinal endoscopy.
[18] M. Tillich,et al. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma. , 1998, AJR. American journal of roentgenology.
[19] K. Lillemoe,et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. , 1996, Annals of surgery.
[20] M. Gonen,et al. Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma , 2001, Annals of surgery.
[21] M. Makuuchi,et al. A new staging system for mass‐forming intrahepatic cholangiocarcinoma , 2001, Cancer.
[22] R. Manfredi,et al. Magnetic resonance imaging of cholangiocarcinoma. , 2004, Seminars in liver disease.
[23] E. Björnsson,et al. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. , 1999, Liver.
[24] S. Curley,et al. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. , 1997, American journal of surgery.
[25] Roger Williams,et al. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. , 1995, Gastroenterology.
[26] F. Prat,et al. Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures , 2000, Gut.
[27] W. Jarnagin,et al. Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. , 1998, Annals of surgery.
[28] B. Langer,et al. Role of US in the detection, characterization, and staging of cholangiocarcinoma. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.
[29] F. Muscari. Prise en charge du cholangiocarcinome hilaire , 2007 .
[30] G. Pond,et al. Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] U. Mansmann,et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. , 2003, Gastroenterology.
[32] M. Bloomston,et al. Location, not Staging, of Cholangiocarcinoma Determines the Role for Adjuvant Chemoradiation Therapy , 2001, The American surgeon.
[33] G. Gores,et al. Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma , 2004, Seminars in liver disease.
[34] T. de Baère,et al. Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. , 2005, Radiology.
[35] R. Chuttani,et al. The combination of stricture dilation, endoscopic needle aspiration, and biliary brushings significantly improves diagnostic yield from malignant bile duct strictures. , 2001, Gastrointestinal endoscopy.
[36] M. Choti,et al. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. , 2005, Journal of vascular and interventional radiology : JVIR.
[37] A. Bergquist,et al. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. , 2002, Endoscopy.
[38] C. Meyer,et al. Liver transplantation for cholangiocarcinoma: results in 207 patients. , 2000, Transplantation.
[39] R. Parks,et al. The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma , 2005, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.
[40] K. McGlynn,et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. , 2005, Gastroenterology.
[41] W. Chapman,et al. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma , 2007, Journal of Gastrointestinal Surgery.
[42] T. Therneau,et al. A Comparison of Routine Cytology and Fluorescence in situ Hybridization for the Detection of Malignant Bile Duct Strictures , 2004, The American Journal of Gastroenterology.
[43] L. Blumgart,et al. Hilar Cholangiocarcinoma: A Review and Commentary , 2000, Annals of Surgical Oncology.
[44] C. Charnsangavej,et al. Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] J. Herman,et al. Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma , 2005, Modern Pathology.
[46] G. D. De Palma,et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. , 2001, Gastrointestinal endoscopy.
[47] Alphonse E. Sirica,et al. Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapy , 2005, Hepatology.
[48] S. Selvaggi. Biliary brushing cytology , 2004, Cytopathology : official journal of the British Society for Clinical Cytology.
[49] Z. Aziz,et al. Gemcitabine and Cisplatin Is a Highly Effective Combination Chemotherapy in Patients With Advanced Cancer of the Gallbladder , 2003, American journal of clinical oncology.